Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Evidence-base medicine: is combination of clopidogrel and proton pump inhibitors safe?

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: SYU, Fei-Kai (Fooyin Univ. Hosp. Taiwan, China & Johns Hopkins Bloomberg Sch. of Public Health, Baltimore, United States of America)
  • Co-author(s): Lai, Sow-Fei (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
    Huang, Yu-Yao (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
    Liu, Keh-Ren (Paochien Medical Care Paochien Hospital, PINGTUNG, China Taiwan)
    Lin, Chien-Liang (Fooyin University Hospital, PINGTUNG, China Taiwan)
  • Abstract:

    Background: Regarding the potential interaction of Proton Pump Inhibitors (PPIs) with Plavix® (Clopidogrel), this potential interaction could lead to a reduction in the level of Clopidogrel's active metabolite and therefore, it is what we are eager to figure out its influences.

    Method:

    Using evidence-based medicine, 822 inpatients with single..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses